Skip to main content
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD logo

BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD — Investor Relations & Filings

Ticker · 000931 ISIN · CNE000001030 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,999 across all filing types
Latest filing 2024-03-01 Legal Proceedings Report
Country CN China
Listing Shenzhen Stock Exchange 000931

About BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD

https://www.centek.com.cn

Beijing Centergate Technologies (Holding) Co., Ltd. focuses on the research, development, production, and distribution of medical and healthcare products. The company’s core operations involve the manufacturing of chemical pharmaceuticals, traditional Chinese medicines, and health supplements. Its product portfolio addresses various therapeutic areas, including cardiovascular health, digestive system treatments, and anti-infective therapies. Additionally, the company provides healthcare services and develops medical devices. Through its specialized subsidiaries, it maintains integrated research and manufacturing capabilities aimed at providing clinical solutions and health management products. The organization emphasizes technological advancement and quality control across its supply chain to meet diverse patient needs and healthcare standards.

Recent filings

Filing Released Lang Actions
关于下属公司涉及诉讼的公告
Legal Proceedings Report Classification · 100% confidence The document is an announcement regarding ongoing litigation involving a subsidiary of the company. It details the nature of the lawsuit, parties involved, claims, and potential impact on the company. It does not contain financial statements or detailed financial analysis but rather provides legal updates and case status. The document is titled as an announcement and is relatively short (2237 characters). This fits the definition of a Legal Proceedings Report (LTR), which covers updates on significant lawsuits or legal matters involving the company.
2024-03-01 Chinese
关于与佳木斯高新技术产业开发区管理委员会签订小容量注射液和口服液制剂项目合作协议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the signing of a cooperation agreement between Beijing Zhongguancun Technology Development (Holdings) Co., Ltd. and the Jiamusi High-tech Industrial Development Zone Management Committee. It details the project overview, investment amount, rights and obligations of both parties, risk warnings, and other related disclosures. The document is relatively short (3593 characters) and serves as a formal announcement of a new investment cooperation agreement rather than a detailed financial report or management discussion. It does not contain financial statements, earnings data, or detailed management analysis. It also does not fit categories like M&A, capital financing, or board changes. The content aligns with a regulatory announcement about a new cooperation agreement and investment intention. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2024-02-29 Chinese
关于召开2024年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2024 second extraordinary general meeting of shareholders (临时股东大会通知). It details the meeting date, voting methods (onsite and online), registration procedures, agenda items, and proxy voting instructions. It does not contain financial statements or results but is an announcement informing shareholders about the meeting and how to participate. The document length is 3914 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2024-02-28 Chinese
关于下属公司北京华素签署盐酸哌甲酯缓释咀嚼片项目技术转让（专利申请权）合同的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Beijing Zhongguancun Technology Development (Holdings) Co., Ltd. regarding a technology transfer contract for a patent application right related to a pharmaceutical product. It details the transaction overview, parties involved, contract terms, payment milestones, project investment and economic benefits, risks, and related approvals. The document is titled as an "announcement" and contains no financial statements or quarterly/yearly financial data. It is a regulatory announcement about a specific transaction (technology transfer) and contract signing, not a full financial report or earnings release. The document length is about 9,510 characters, which is substantial but the content is clearly an announcement of a contract and transaction rather than a report or presentation. Therefore, the most appropriate classification is "Capital/Financing Update (CAP)" as it relates to a significant technology transfer transaction and contract signing impacting the company's capital and business operations.
2024-02-28 Chinese
关于下属公司山东华素与国美地产签署写字楼租赁合同暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a related-party transaction involving the signing of an office lease contract between a subsidiary of the company and a related party (国美地产). It details the terms of the lease, the parties involved, the approval process by the board, and the impact on the company. There are no financial statements or comprehensive financial data presented, nor is this a report of financial results or management discussion. The document is a formal announcement of a corporate transaction (a related-party lease agreement) and not a financial report or earnings release. It fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2024-02-28 Chinese
第八届董事会2024年度第二次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is titled as a resolution announcement from the company's eighth board of directors for the 2024 second interim meeting. It details decisions made by the board regarding leasing contracts, technology transfer agreements, financing guarantees, and the scheduling of a second interim shareholders' meeting in 2024. The content focuses on board meeting resolutions and approvals rather than full financial statements or detailed financial performance. There is no indication of comprehensive financial data or audit results, nor is it a transcript or presentation. The document is a formal announcement of board meeting decisions, which fits the category of Board/Management Information (MANG). The document length is about 4516 characters, which is consistent with a detailed board meeting resolution announcement rather than a full report or regulatory filing. Therefore, the classification is MANG with high confidence.
2024-02-28 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.